USPTO serial 79451797
LIRO THERAPEUTICS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- HERRERA-MARCUS, ROSELLE MORALDE
- Law office
- TMO LAW OFFICE 124
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with LIRO THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business management, organisation and administration; strategic development, business management and implementation of business plans for the development and commercialisation of drugs and therapies; business management services relating to commercialisation of technology, processes and products; promoting public awareness in the field of cancer research; advisory, consultancy, business management and organisational services in relation to the foregoing; providing information, including online, in regard to all the aforesaid services. | ACTIVE | — |
| 042 | Scientific services and related research services; scientific research; chemistry research; medical research; scientific and medical research and development; product development; scientific research and product development in the field of pharmaceuticals and biotechnology; research and development of pharmaceuticals for the treatment of cancer; medical research in the field of oncology; scientific research for medical purposes in the field of cancerous diseases; laboratory research and analysis; pharmaceutical research; drug development; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; assessing the safety and efficiency relating to pharmaceuticals; laboratory testing; quality control; advisory and consultancy services in relation to the foregoing; providing information, including online, in regard to all the aforesaid services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 24, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 24, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 12, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |